06:01 AM
The healthcare landscape has transformed drastically over the years and we have found ourselves in a situation where both patients and consumers alike are becoming more engaged and involved in their own health. Consequently, this has given rise to a need to find a more personalised way of managing healthcare for each individual. In addition, the onset of the COVID-19 pandemic has also forced us to adapt and switch to utilising digital technology to treat medical conditions instead of delivering more traditional face to face episodic care. This further cemented the dire need for a sound digital infrastructure to cater to the differing healthcare needs of each individual.
Pharma transformation
published : 1 Mar 2021 at 12:30
21
The Covid-19 pandemic has created urgent demand for health innovations to better serve individuals, organisations and entire societies. The pharmaceutical industry has been on the frontlines of the challenge as it races against time to find solutions.
The development of coronavirus vaccines in a matter of months is an achievement that few would have thought possible. The fact that it happened demonstrates the resilience of the sector and its ability to harness research talent to meet urgent challenges.
With production now up and running, the next challenge is distribution and actually getting the shots into people s arms. This presents a new set of challenges for the public-sector side of the healthcare system.
Taiwan ranks 2nd in first Asia-Pacific Personalized Health Index
01/31/2021 02:26 PM
CNA file photo
Taipei, Jan. 31 (CNA) Taiwan ranked second behind Singapore, out of 11 Asia Pacific countries in a new health index that measures progress toward personalized healthcare.
The Economist Intelligence Unit (EIU) report Asia-Pacific Personalized Health Index, released on Jan. 28, praised Taiwan for its strong digital infrastructure, comprehensive health data collection, increasing data interoperability, and signs of a robust personalized health workforce.
The report, however, said Taiwan could further strengthen its position by increasing investment in healthcare research and development and improving the accessibility of data for research. Clearer and more connected strategies concerning the use of personalized health-enabling technologies such as artificial intelligence as well as improving equity in healthcare access and quality could also be a focus for Taiwan moving forwa
Personalised health services in India have significant cost barriers: Report
Photo: iStock
Share Via
Read Full Story
NEW DELHI :
Personalised healthcare services in India have limited availability, often only in more industrialised, urban areas with significant cost barriers, revealed the Asia-Pacific Personalised Health Index, developed by the Copenhagen Institute for Future Studies in partnership with Roche. The Index was launched at event hosted by Economist Intelligence Unit (The EIU) on Thursday.
The report which reveals positive progress towards Personalised Healthcare across 11 countries in Asia-Pacific (Australia, China, Japan, India, Indonesia, Malaysia, Singapore, South Korea, Taiwan, Thailand and New Zealand) ranked India at the 10th position just behind Indonesia which is at 11th spot.
India ranks 10th in Asia-Pacific Personalised Health Index
The Personalised Health Index measures performance against 27 different indicators of personalised health across four categories called Vital Signs .
Share Via Email
| A+A A- By PTI
NEW DELHI: India ranked 10th out of 11 Asia Pacific countries in a newly-launched health index to measure the progress towards personalised healthcare.
The Economist Intelligence Unit (EIU) report Asia-Pacific Personalised Health Index measures the readiness of 11 health systems across the region Australia, China, Japan, India, Indonesia, Malaysia, Singapore, South Korea, Taiwan, Thailand and New Zealand in adopting personalised healthcare, enabling the right care to be tailored to the right person at the right time.